» Articles » PMID: 38993570

ETS1-mediated Regulation of SOAT1 Enhances the Malignant Phenotype of Oral Squamous Cell Carcinoma and Induces Tumor-associated Macrophages M2-like Polarization

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2024 Jul 12
PMID 38993570
Authors
Affiliations
Soon will be listed here.
Abstract

Oral squamous cell carcinoma (OSCC) is an aggressive cancer that poses a substantial threat to human life and quality of life globally. Lipid metabolism reprogramming significantly influences tumor development, affecting not only tumor cells but also tumor-associated macrophages (TAMs) infiltration. , a critical enzyme in lipid metabolism, holds high prognostic value in various cancers. This study revealed that is highly expressed in OSCC tissues and positively correlated with M2 TAMs infiltration. Increased expression enhanced the capabilities of cell proliferation, tumor sphere formation, migration, and invasion in OSCC cells, upregulated the SREBP1-regulated adipogenic pathway, activated the PI3K/AKT/mTOR pathway and promoted M2-like polarization of TAMs, thereby contributing to OSCC growth both and . Additionally, we explored the upstream transcription factors that regulate and discovered that positively regulates expression levels. Knockdown of effectively inhibited the malignant phenotype of OSCC cells, whereas restoring expression significantly mitigated this suppression. Based on these findings, we suggest that is regulated by and plays a pivotal role in the development of OSCC by facilitating lipid metabolism and M2-like polarization of TAMs. We propose that is a promising target for OSCC therapy with tremendous potential.

Citing Articles

Effects of macrophages in OSCC progression.

Dong X, Dong C, Li B Front Immunol. 2025; 15:1517886.

PMID: 39877372 PMC: 11772471. DOI: 10.3389/fimmu.2024.1517886.


SAR1A Induces Cell Growth and Epithelial-Mesenchymal Transition Through the PI3K/AKT/mTOR Pathway in Head and Neck Squamous Cell Carcinoma: An In Vitro and In Vivo Study.

Fang S, Wang J, Liu T, Jiang Y, Hua Q Biomedicines. 2024; 12(11).

PMID: 39595043 PMC: 11591717. DOI: 10.3390/biomedicines12112477.


USP8-mediated PTK7 promotes PIK3CB-related pathway to accelerate the malignant progression of non-small cell lung cancer.

Kong W, Feng X, Yu Z, Qi X, Zhao Z Thorac Cancer. 2024; 16(1):e15485.

PMID: 39552193 PMC: 11729734. DOI: 10.1111/1759-7714.15485.


ETS1 promotes cisplatin resistance of NSCLC cells by promoting GRP78 transcription.

Liu C, Jiang J, Luo J, Zhang Y, Yang C, Shi J Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39521757 DOI: 10.1007/s00210-024-03574-x.

References
1.
Xu Y, Xu Y, Zhu Y, Sun H, Juguilon C, Li F . Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis. Mol Ther. 2019; 28(1):202-216. PMC: 6952168. DOI: 10.1016/j.ymthe.2019.09.008. View

2.
Wang J, Jiang C, Li N, Wang F, Xu Y, Shen Z . The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway. Cell Death Dis. 2020; 11(8):682. PMC: 7443145. DOI: 10.1038/s41419-020-02851-w. View

3.
Vishnoi K, Viswakarma N, Rana A, Rana B . Transcription Factors in Cancer Development and Therapy. Cancers (Basel). 2020; 12(8). PMC: 7464564. DOI: 10.3390/cancers12082296. View

4.
Guo X, Zhou S, Yang Z, Li Z, Hu W, Dai L . Comprehensive Analysis of as a Prognostic Biomarker and Its Association With Immune Infiltration in Glioma. Front Oncol. 2022; 12:896433. PMC: 9133349. DOI: 10.3389/fonc.2022.896433. View

5.
Liang L, Liu Y, Jiang S, Huang J, He H, Shen L . Novel Circulating Tumour Cell-Related Risk Model Indicates Prognosis and Immune Infiltration in Lung Adenocarcinoma. J Immunol Res. 2022; 2022:6521290. PMC: 9168189. DOI: 10.1155/2022/6521290. View